<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Alliance A071801 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/alliance-a071801/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 12 Oct 2026 20:00:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Alliance A071801 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Split-Dose Radiation After Surgery Cuts Brain Tumor Recurrence in Landmark Trial</title>
		<link>https://bioengineer.org/split-dose-radiation-after-surgery-cuts-brain-tumor-recurrence-in-landmark-trial/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 12 Oct 2026 20:00:01 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Alliance A071801]]></category>
		<category><![CDATA[ASTRO]]></category>
		<category><![CDATA[brain metastases]]></category>
		<category><![CDATA[cancer recurrence]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[fractionated radiation]]></category>
		<category><![CDATA[local control]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[overall survival]]></category>
		<category><![CDATA[radiation oncology]]></category>
		<category><![CDATA[stereotactic radiosurgery]]></category>
		<category><![CDATA[surgical cavity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=416350</guid>

					<description><![CDATA[A randomized phase III Alliance trial found that delivering postoperative radiosurgery in three to five sessions instead of one significantly reduced recurrence at the surgical site and was associated with nine months longer median survival in patients with large brain metastases.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">416350</post-id>	</item>
	</channel>
</rss>
